|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-21.20/--
|
Enterprise Value
3.29M
|
Balance Sheet |
Book Value Per Share
9.30
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
9.93M
|
Operating Revenue Per Share
15.75
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/09/28 16:04 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas. |